查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470585

CRISPR 技術市場：按產品、應用和最終用戶分類 - 2024-2030 年全球預測

CRISPR Technology Market by Offering (Product, Services), Application (Agricultural, Biomedical, Industrial), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年CRISPR技術市場規模為32.5億美元，預計2024年將達到37.7億美元，2030年將達到94.9億美元，複合年成長率為16.52%。

成簇規則間隔短回文重複序列 (CRISPR) 是源自細菌防禦機制的高度精確且高效的基因組編輯工具，可對生物體基因組內的 DNA 序列進行有針對性的操作。這種創新的生物技術工具能夠利用 RNA 引導的 Cas9 核酸酶進行精確的基因組編輯，從而促進醫療保健、農業和生質能源產業的標靶基因修飾。研究活動資金的增加、基因治療的進步、遺傳病患病率的增加以及對更有效率作物生產方法的需求正在推動 CRISPR 技術的使用增加。然而，圍繞基因編輯（特別是在人類生殖細胞中）的倫理問題以及各個地區的監管障礙可能會阻礙 CRISPR 產品的採用和商業化。然而，藥物發現的進步包括創造具有更高營養價值和抗病蟲害能力的新型作物，以及使用 CRISPR 系統針對特定標靶篩檢大型化合物庫，為 CRISPR 創造了利潤豐厚的機會。

主要市場統計
基準年[2023] 32.5億美元
預測年份 [2024] 37.7億美元
預測年份 [2030] 94.9億美元
複合年成長率（%） 16.52%

提供的 CRISPR套件和試劑的使用迅速增加，研究活動和產品改進取得進展

CRISPR 技術中使用的酵素是基因編輯的關鍵組件，其中 Cas9 是最常用的酵素。這些酵素充當分子剪刀，可以精確切割和修飾 DNA 序列。引導 RNA 對於引導 Cas 酶靶向細胞 DNA 序列中的特定基因組位置非常重要。研究人員可能需要針對特定目標設計的自訂gRNA，或者他們可能更喜歡預先設計的涵蓋模型生物或細胞株中常見基因目標的文庫。 CRISPR套件和試劑產品系列包括質體、Cas9蛋白、sgRNA（單嚮導RNA）、表達載體、同源定向修復（HDR）模板、病毒遞送系統（如腺結合病毒（AAV）和慢病毒）以及溶核產品包括基於電穿孔的轉染方法，包括轉染裝置和脂轉染試劑。細胞株工程服務利用CRISPR技術修飾細胞以引入或增強特定功能，使研究人員能夠研究基因功能並開發標靶治療。這項服務對於專門從事藥物發現、基因治療和再生醫學的生物製藥公司和學術機構至關重要。引導 RNA (gRNA) 和載體系統的設計和建構對於 CRISPR 介導的基因編輯實驗至關重要。研究人員依靠這些服務來產生高效、特異性的敲除或敲入模型，這對於功能基因組學、標靶檢驗研究和疾病建模等應用尤其重要。基於 CRISPR 的篩檢服務對於識別新藥物標靶和闡明生物途徑中重要的遺傳交互作用至關重要。

擴大CRISPR技術在農業領域的應用

在農業領域，CRISPR 技術為作物改良、抗病蟲害以及提高產量提供了解決方案。 CRISPR技術也應用於生物醫學研究，如遺傳疾病的基因治療、癌症免疫治療、感染疾病治療等。 CRISPR技術的工業應用包括微生物工程、生質燃料、生醫材料和環境生物修復。

最終用戶：CRISPR技術在生技公司的潛在應用

學術和政府研究機構主要專注於CRISPR技術的基礎研究和新應用的開發。他們對 CRISPR 的需求將產生先進的知識和工具，以了解基因編輯背後的機制，針對人類基因組中的特定基因，並找到各種遺傳疾病的潛在治療解決方案。使用 CRISPR 技術的生物技術公司專注於商業性應用的應用研究，例如最佳化工業、增強工業生物過程或直接向消費者銷售基因工程產品。製藥公司正在將 CRISPR 技術應用於治療，特別是針對遺傳性疾病、癌症和肥胖等文明病的藥物發現和藥物開發。

區域洞察

在美國，由於廣泛的研究和開發活動、公共和私營部門的大量投資以及生物資訊學的進步，CRISPR 技術市場正在經歷顯著成長。此外，農業、生物技術、藥物發現和治療等強勁且穩定成長的行業正在推動對 CRISPR 技術的需求。亞太地區擁有不斷成長的生物製藥產業，該產業正在大力投資基因編輯技術，以促進農業進步和疾病治療應用。此外，政府對基因組學研究的支持以及與國際組織的戰略聯盟等因素正在加速該地區的市場成長。由於其完善的製藥基礎設施和各個組織對基因組編輯研究計劃的資助，歐洲經歷了可觀的成長。此外，中東和非洲子區隔放在 CRISPR 在鐮鐮狀性貧血和 BETA 地中海貧血等疾病的治療應用。

FPNV定位矩陣

FPNV定位矩陣對於評估CRISPR技術市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對 CRISPR 技術市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.CRISPR技術市場的市場規模與預測為何？

2.在CRISPR技術市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.CRISPR技術市場的技術趨勢和法規結構是什麼？

4. CRISPR技術市場主要廠商的市場佔有率是多少？

5.進入CRISPR技術市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對遺傳疾病新疫苗和治療方法的需求增加
      • 增加對生物技術和製藥領域的私人和公共投資
    • 抑制因素
      • 與政府監管相關的高成本和複雜性
    • 機會
      • CRISPR技術的進步與改進
      • CRISPR技術在農業領域的潛在應用
    • 任務
      • 與 CRISPR 技術相關的技術挑戰和倫理問題
  • 市場區隔分析
    • 我們提供什麼：由於研究活動的激增和產品的改進，CRISPR套件和試劑的使用不斷增加。
    • 應用：擴大 CRISPR 技術在農業領域的應用
    • 最終用戶：CRISPR技術在生技公司的潛在應用
  • 市場趨勢分析
    • 主要參與者加強研發力度，擴大 CRISPR 技術在美洲農業的應用
    • 持續研究和策略合作，利用 CRISPR 技術提高農業生產力，並將 CRISPR 引入亞太地區的就地檢驗
    • 由於歐洲、中東和非洲地區研究活動的增加，在疾病管理中使用 CRISPR 技術的核准不斷增加
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化
    • CRISPR 正成為生質能源生產的可行解決方案
    • 擴大 CRISPR 技術的專利版圖

第6章 CRISPR 技術市場：透過提供

  • 產品
  • 服務

第7章 CRISPR 技術市場：依應用分類

  • 農業
  • 生物醫學
  • 產業

第 8 章 CRISPR 技術市場：按最終用戶分類

  • 學術和政府研究機構
  • 生技公司

第9章 美洲CRISPR技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區CRISPR技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的CRISPR技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • RoslinCT 生產基於 CRISPR 的治療方法
    • 第一種人類 CRISPR 藥物取得進展
    • ERS Genomics Limited (ERS) 與 Syngene International 簽署許可協議
    • Revvity (RVTY) 推出新服務以擴大編輯技術的使用範圍
    • Pencil Biosciences 融資 560 萬英鎊，用於推進罕見疾病的基因編輯
    • 整合式 DNA Technologies 與 Aldevron 建立策略合作夥伴關係，為細胞和基因治療開發商提供關鍵 CRISPR 組件
    • Bedoukian Research Inc. 與 Inscripta 合作，永續開發和生產天然成分。
    • Scribe 宣布合作加速基於 CRISPR 的體內基因藥物的開發
    • Vertex 表示計劃在 FDA 做出決定之前推出首個 Crispr 基因編輯療法
    • Sherlock Biosciences 收購 Sense Biodetection
    • Intellia Therapeutics 宣布收購 Relight Therapeutics

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-B1685377A648

[183 Pages Report] The CRISPR Technology Market size was estimated at USD 3.25 billion in 2023 and expected to reach USD 3.77 billion in 2024, at a CAGR 16.52% to reach USD 9.49 billion by 2030.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a highly precise and efficient genome-editing tool derived from a bacterial defense mechanism, which allows for targeted manipulation of the DNA sequence within an organism's genome. This innovative biotechnology tool enables precise genome editing through RNA-guided Cas9 nucleases, facilitating targeted genetic modifications across healthcare, agriculture, and bioenergy industries. Increased funding for research activities, advancements in gene therapy, the growing prevalence of genetic disorders, and the need for more efficient crop production methods increase the use of CRISPR technology. However, ethical concerns surrounding gene editing, especially in human germline cells, and regulatory hurdles in different regions may impede the adoption or commercialization of CRISPR products. Nevertheless, creating new genetically modified crops (GMO) with enhanced nutritional value or resistance to pests and diseases and advancing drug discovery by screening large libraries of compounds against specific targets using CRISPR systems creates lucrative opportunities for the CRISPR technology market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 9.49 billion
CAGR (%) 16.52%

Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements

The enzymes used in CRISPR technology are critical components for gene editing, with Cas9 being the most commonly utilized enzyme. These enzymes function as molecular scissors, enabling precise cutting and modification of DNA sequences. Guide RNAs have significance in directing the Cas enzymes to target specific genomic locations within a cell's DNA sequence. Researchers may require custom gRNAs designed for their particular targets or prefer pre-designed libraries that cover common gene targets in model organisms or cell lines. The CRISPR kits & reagent product portfolio comprises a range of products, including plasmids, Cas9 proteins, sgRNAs (single guide RNAs), expression vectors, homology-directed repair (HDR) templates, viral delivery systems such as adeno-associated viruses (AAV) or lentiviruses, electroporation-based transfection methods including nucleofection devices or lipofection reagents. Cell line engineering services involve modifying cells to introduce or enhance specific features using CRISPR technology, enabling researchers to study gene function and develop targeted therapies. This service is crucial for biopharmaceutical companies and academic institutions focused on drug discovery, gene therapy, and regenerative medicine. The design and construction of guide RNAs (gRNAs) and vector systems are essential in CRISPR-mediated gene editing experiments. Researchers rely on these services for generating knockout or knock-in models with high efficiency and specificity, which is particularly important in applications such as functional genomics, target validation studies, and disease modeling. CRISPR-based screening services are pivotal for identifying novel drug targets or uncovering critical genetic interactions within biological pathways.

Application: Proliferating use of CRISPR technology in the agricultural sector

In the agricultural sector, CRISPR technology provides solutions for crop improvement, pest and disease resistance, and increased yield. CRISPR technology has applications in biomedical research, such as gene therapy for genetic disorders, cancer immunotherapy, and infectious disease treatment. The industrial applications of CRISPR technology encompass microbial engineering, biofuels, biomaterials, and environmental bioremediation.

End-User: Potential application of CRISPR technology in biotechnology companies

Academic and government research institutes primarily focus on fundamental research and developing novel applications for CRISPR technology. Their need-based preference for CRISPR revolves around generating advanced knowledge and tools to understand the mechanism behind gene editing, targeting specific genes in the human genome, and finding potential therapeutic solutions for various genetic disorders. Biotechnology companies utilizing CRISPR technology focus on applied research with commercial applications such as agriculture optimization, industrial bioprocessing enhancement, or direct-to-consumer genetic modification products. Pharmaceutical companies involve therapeutic applications of CRISPR technology for drug discovery and development, specifically targeting genetic diseases, cancers, or lifestyle disorders such as obesity.

Regional Insights

In America, the CRISPR technology market represents significant growth due to extensive research and development activities, substantial investments by both public and private sectors, and advances in bioinformatics. In addition, robust and steadily growing sectors such as agriculture, biotechnology, drug discovery, and therapeutics increased demand for CRISPR technology. The APAC region boasts increasing biopharmaceutical industries investing heavily in gene-editing technologies for agricultural advancements and disease treatment applications. Additionally, factors such as government support for genomics research and strategic collaborations with international organizations have accelerated market growth in this region. Europe has experienced considerable growth due to its well-established pharmaceutical infrastructure and funding from various organizations for genome editing research projects. Moreover, the Middle-East and Africa sub-segments focus on therapeutic applications of CRISPR for diseases such as sickle cell anemia and beta-thalassemia.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the CRISPR Technology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CRISPR Technology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Technology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied StemCell, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., ERS Genomics Limited, Function Oncology, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Scribe Therapeutics, Sherlock Biosciences, Inc., Synthego Corporation, Takara Holdings Inc., Thermo Fisher Scientific Inc., ToolGen, Inc., TriLink BioTechnologies by Maravai Intermediate Holdings, LLC, Twist Bioscience Corporation, and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Product
      • Enzymes
      • Guide RNA
      • Kits & Reagents
    • Services
      • Cell Line Engineering
      • gRNA Design & Vector Construction
      • Screening Services
  • Application
    • Agricultural
    • Biomedical
    • Industrial
  • End User
    • Academics & Government Research Institutes
    • Biotechnology Companies
      • Agricultural Companies
      • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Georgia
        • Illinois
        • Kentucky
        • Michigan
        • Mississippi
        • New Jersey
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the CRISPR Technology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CRISPR Technology Market?

3. What are the technology trends and regulatory frameworks in the CRISPR Technology Market?

4. What is the market share of the leading vendors in the CRISPR Technology Market?

5. Which modes and strategic moves are suitable for entering the CRISPR Technology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
      • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complexities involved in the government regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CRISPR technology
      • 5.1.3.2. Potential use of CRISPR technology in the agriculture sector
    • 5.1.4. Challenges
      • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR technology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements
    • 5.2.2. Application: Proliferating use of CRISPR technology in the agricultural sector
    • 5.2.3. End-User: Potential application of CRISPR technology in biotechnology companies
  • 5.3. Market Trend Analysis
    • 5.3.1. Increasing research and development by key players and growing application of CRISPR technology in agriculture in the Americas
    • 5.3.2. Ongoing research and strategic collaborations for higher agricultural productivity using CRISPR technologies coupled with adoption of CRISPR in point-of-care testing in the APAC region
    • 5.3.3. Increasing approvals for the usage of CRISPR technology for disease management coupled with growing research activities in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis
  • 5.8. Client Customization
    • 5.8.1. CRISPR becoming a viable solution for bioenergy production
    • 5.8.2. Expanding patent landscape for CRISPR technology

6. CRISPR Technology Market, by Offering

  • 6.1. Introduction
  • 6.2. Product
  • 6.3. Services

7. CRISPR Technology Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural
  • 7.3. Biomedical
  • 7.4. Industrial

8. CRISPR Technology Market, by End User

  • 8.1. Introduction
  • 8.2. Academics & Government Research Institutes
  • 8.3. Biotechnology Companies

9. Americas CRISPR Technology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific CRISPR Technology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa CRISPR Technology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. RoslinCT Manufacture CRISPR-Based Therapy
    • 12.3.2. First Human CRISPR Drug Moves Forward
    • 12.3.3. ERS Genomics Limited ('ERS') Completes Licensing Agreement With Syngene International
    • 12.3.4. Revvity's (RVTY) New Launch to Widen Access to Editing Technology
    • 12.3.5. Pencil Biosciences Raises GBP 5.6 Million to Advance Gene Editing for Rare Diseases
    • 12.3.6. Integrated DNA Technologies and Aldevron Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers
    • 12.3.7. Bedoukian Research Inc. Partners with Inscripta to Sustainably Develop and Manufacture Naturally Produced Ingredients
    • 12.3.8. Scribe Announces Collaboration to Accelerate In Vivo CRISPR-Based Genetic Medicines
    • 12.3.9. Vertex Teases Launch Plans for First Crispr Gene Editing Therapy Ahead of FDA Decision
    • 12.3.10. Sherlock Biosciences to Acquire Sense Biodetection
    • 12.3.11. Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CRISPR TECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR TECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CRISPR TECHNOLOGY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRISPR TECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GUIDE RNA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GUIDE RNA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GRNA DESIGN & VECTOR CONSTRUCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GRNA DESIGN & VECTOR CONSTRUCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOMEDICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 212. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 223. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 224. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 236. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 247. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 248. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 249. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 259. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 260. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 261. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 271. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 272. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 273. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 297. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 298. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 299. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 302. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 303. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 304. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 309. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 310. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 311. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 312. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 313. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 314. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 315. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 321. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 322. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 323. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 326. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 327. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 330. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 333. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 334. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 335. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 336. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 337. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 338. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 339. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 342. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 345. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 346. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 347. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 348. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 349. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 350. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 351. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 354. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 355. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 356. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 357. ISRAEL CRISPR TEC